Zero Gravity Solutions (ZGSI) 10-Q 15 May 15 2015 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2015	Apr. 30, 2015
Document Information [Line Items]
Entity Registrant Name	Zero Gravity Solutions, Inc.
Entity Central Index Key	1574186
Current Fiscal Year End Date	-19
Entity Filer Category	Smaller Reporting Company
Trading Symbol	ZGSI
Entity Common Stock, Shares Outstanding		33,507,847
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Mar-15
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2015

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Mar. 31, 2015	Dec. 31, 2014
CURRENT ASSETS
Cash	$577,772	$253,677
Prepaid Expenses	180,524	213,781
Accounts Receivable	830	1,325
Inventory	25,103	18,592
Total Current Assets	784,229	487,375
Property and Equipment - net	45,572	44,142
OTHER ASSETS
Deposit	6,756	6,356
Advance on Future Royalties - Related Parties	83,930	50,356
TOTAL ASSETS	920,487	588,229
CURRENT LIABILITIES
Accounts Payable and Accrued Liabilities	118,480	155,960
Notes Payable Related Party	0	11,000
Notes Payable	69,760	104,647
Total Current Liabilities	188,240	271,607
STOCKHOLDERS' EQUITY
Common stock; 100,000,000 shares authorized, at $0.001 par value, 33,507,847 and 30,844,597 shares issued and outstanding, respectively	33,508	30,845
Common stock to be issued	0	25,000
Additional paid-in capital	6,295,332	4,748,285
Accumulated other comprehensive loss	-9,408	-1,847
Accumulated deficit	-5,587,185	-4,485,661
Total Stockholders' Equity	732,247	316,622
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$920,487	$588,229

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets [Parenthetical] (USD $)	Mar. 31, 2015	Dec. 31, 2014
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share)	$0.00	$0.00
Common Stock, Shares, Issued	33,507,847	30,844,597
Common Stock, Shares, Outstanding	33,507,847	30,844,597

Consolidated_Statements_of_Ope

Consolidated Statements of Operations and Other Comprehensive Loss (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
OPERATING EXPENSES
General and Administrative	$1,092,142	$525,566
Research and Development	8,100	25,774
Total Operating Expenses	1,100,242	551,340
LOSS FROM OPERATIONS	-1,100,242	-551,340
OTHER EXPENSES
Interest Expense	-1,282	-572
Total Other Income (Expenses)	-1,282	-572
NET LOSS	-1,101,524	-551,912
NET LOSS PER SHARE - BASIC AND DILUTED (in dollars per share)	($0.03)	($0.02)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED (in shares)	32,539,433	26,164,382
OTHER COMPREHENSIVE LOSS
Net Loss	-1,101,524	-551,912
Foreign currency translation loss	-7,561	-471
COMPREHENSIVE LOSS	($1,109,085)	($552,383)

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	($1,101,524)	($551,912)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation expense	1,434	0
Common stock issued for services	50,000	25,000
Warrants issued for services	291,710	141,530
Imputed interest - related party	0	33
Changes in operating assets and liabilities:
Receivables	495	0
Prepaids	33,257	-4,132
Advance on future royalties - related parties	-33,574	-7,500
Inventory	-6,511	0
Deposit	-400	0
Accounts payable and accrued liabilities	-37,480	-42,838
Accrued interest	0	-1,143
Net Cash Used in Operating Activities	-802,593	-440,962
CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid to purchase equipment	-2,864	-2,838
Net Cash Used in Investing Activities	-2,864	-2,838
CASH FLOWS FROM FINANCING ACTIVITIES
Payments of notes payable	-34,887	0
Repayment on notes payable - related party	-11,000	-26,000
Proceeds from sale of common stock	1,278,500	398,000
Payment of offering costs	-95,500	-33,900
Net Cash Provided by Financing Activities	1,137,113	338,100
EFFECT OF EXCHANGE RATES ON CASH	-7,561	-471
NET (DECREASE) INCREASE IN CASH	324,095	-106,171
CASH AT BEGINNING OF PERIOD	253,677	292,935
CASH AT END OF PERIOD	577,772	186,764
CASH PAID FOR:
Interest	0	0
Income Taxes	0	0
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING ANDD FINANCING ACTIVITIES:
Warrants issued as direct offering costs	$87,355	$51,036

ORGANIZATION_HISTORY_AND_NATUR

ORGANIZATION, HISTORY AND NATURE OF OPERATIONS	3 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1 – ORGANIZATION, HISTORY AND NATURE OF OPERATIONS
	The Company was organized on August 19, 1983 in the State of Delaware, under the name Monolith Ventures, Inc. to acquire and develop mineral properties.
	On January 12, 2012, the Company amended its Articles of Incorporation to change its name to ElectroHealing Technologies, Inc. under the laws of the State of Nevada, in anticipation of a merger which did not occur.
	On January 11, 2013, the Company amended its Articles of Incorporation to change its name to Zero Gravity Solutions, Inc. (“the Company”) (“ZGSI”), pursuant to the acquisition of intellectual property on December 3, 2012.
	On October 29, 2013, the Company formed its wholly-owned subsidiary in the State of Delaware, Zero Gravity Solutions, Inc., which had no operations through December 31, 2013.
	On December 16, 2013, the Company acquired 100% of Zero Gravity Solutions, Ltd. (“ZGSL”). This was a dormant U.K. company, which had no operations prior to acquisition and through December 31, 2013.
	On June 13, 2014, the Company formed its wholly-owned subsidiary in the State of Florida, Bam Agricultural Solutions, Inc.
	On August 19, 2014, the Company formed its wholly-owned subsidiary in the U.K., Bam Agricultural Solutions, Ltd.
	On December 17, 2014, the Company formed its wholly-owned subsidiary in the State of Florida, Zero Gravity Life Sciences, Inc.
	The Company owns proprietary technology for its first commercial product, BAM-FXTM that can boost the nutritional value and enhance the immune system of food crops without the use of Genetic Modification.
	The Company’s mission is to improve life on earth by applying intellectual property and technology designed for and derived from six NASA enabled flights over the last five years through utilization of the unique long-term microgravity environment platform of the International Space Station (ISS). The Company’s initial projects will be directed to providing solutions to critical world food crop challenges.
	Further, the Company is focused on industrializing and commercializing scientific breakthroughs in the area of patentable stem cell technologies through developing advances in plant, animal and human biology based on intellectual property designed for and derived from multiple experiments on the ISS.
	Basis of Presentation
	Certain information or footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted, pursuant to the rules and regulations of the Securities and Exchange Commission for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. It is management's opinion, however, that all material adjustments (consisting of normal recurring adjustments) have been made which are necessary for a fair financial statement presentation. The interim results for the period ended March 31, 2015, are not necessarily indicative of results for the full fiscal year. These unaudited financial statements should be read in conjunction with the audited financial statements and the notes thereto for the year ended December 31, 2014.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Cash and Cash Equivalents
	For purposes of the statement of cash flows, the Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company had no cash equivalents at March 31, 2015 and December 31, 2014.
	Use of Estimates
	In preparing financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses in the statement of operations. Actual results could differ from those estimates.
	Principles of Consolidation
	The accompanying unaudited interim condensed consolidated financial statements include the accounts of Zero Gravity Solutions, Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
	Inventory
	Inventory is valued on a lower of first-in, first out (FIFO) cost or market basis. At March 31, 2015 raw materials on hand was $8,962 and finished product inventory was valued at $16,141.
	Property and Equipment
	Property and equipment is stated at cost, less accumulated depreciation. Expenditures for maintenance and repairs are charged to expense as incurred.
	Depreciation is computed on a straight-line basis over estimated useful lives. Property and equipment is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. There were no impairment charges taken during the period ended March 31, 2015.
	Fair Value of Financial Instruments and Derivative Financial Instruments
	The Company applies the accounting guidance under Financial Accounting Standards Board (“FASB”) ASC 820-10, “Fair Value Measurements”, as well as certain related FASB staff positions.  This guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact business and considers assumptions that marketplace participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of non-performance.
	The guidance also establishes a fair value hierarchy for measurements of fair value as follows:
	·	Level 1 – quoted market prices in active markets for identical assets or liabilities.
	·	Level 2 - inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	·	Level 3 – unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	The carrying amounts of the Company’s short-term financial instruments, accounts payable and accrued liabilities and notes payable – related party, approximate fair value due to the relatively short period to maturity for these instruments.
	Stock based compensation
	We account for stock options in accordance with Accounting Standards Codification (“ASC”) 718: Compensation - Stock Compensation (“ASC 718”). ASC 718 requires generally that all equity awards be accounted for at their “fair value.” This fair value is measured on the grant date for stock-settled awards, and at subsequent exercise or settlement for cash-settled awards. Fair value is equal to the underlying value of the stock for “full-value” awards such as restricted stock and performance shares, and estimated using an option-pricing model with traditional inputs for “appreciation” awards such as stock options and stock appreciation rights.
	Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from our initial estimates: previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in general and administrative expense.
	Basic (Loss) per Common Share
	Basic (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity.
	The Company had the following potential common stock equivalents at March 31, 2015 and December 31, 2014:
			31-Mar-15		December 31. 2014
	Stock Warrants (Exercise price - $.50/share) (see Note 5)			2,746,900		1,926,900
	Total common stock equivalents			2,746,900		1,926,900
	Research and Development
	The Company expenses all research and development costs as incurred for which there is no alternative future use.
	Foreign Currency Transactions
	The consolidated financial statements are presented in United States Dollars. The Company has a bank account in foreign currency. The balance of this bank account was translated from its local currency (British Pounds) into the reporting currency, U.S. dollars, using period end exchange rates. The resulting translation adjustments were recorded as a separate component of accumulated other comprehensive loss. Revenues and expenses were translated using weighted average exchange rate for the period.
	Transaction gains and losses resulting from foreign currency transactions were recorded as foreign exchange gains or losses in the consolidated statement of operations. The Company did not enter into any financial instruments to offset the impact of foreign currency fluctuations.
	Income Taxes
	The Company accounts for income taxes in accordance with accounting guidance now codified as FASB ASC Topic 740, “Income Taxes,” which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all deferred tax assets will not be realized.
	Accounting guidance now codified as FASB ASC Topic 740-20, “Income Taxes – Intraperiod Tax Allocation,” clarifies the accounting for uncertainties in income taxes recognized in accordance with FASB ASC Topic 740-20 by prescribing guidance for the recognition, de-recognition and measurement in financial statements of income tax positions taken in previously filed tax returns or tax positions expected to be taken in tax returns, including a decision whether to file or not to file in a particular jurisdiction. FASB ASC Topic 740-20 requires that any liability created for unrecognized tax benefits is disclosed. The application of FASB ASC Topic 740-20 may also affect the tax bases of assets and liabilities and therefore may change or create deferred tax liabilities or assets. The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense.
	At March 31, 2015 and December 31, 2014, the Company did not record any liabilities for uncertain tax positions.

GOING_CONCERN

GOING CONCERN	3 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern, Disclosure [Text Block]	NOTE 3 – GOING CONCERN
	As reflected in the accompanying financial statements, the Company has an accumulated deficit of $5,587,185 and net cash used in operations of $802,993 for the period ended March 31, 2015.
	The Company’s financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established any source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.
	In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plans to obtain such resources for the Company include obtaining capital from certain related parties, management and significant shareholders and through private placement of securities sufficient to meet its minimal operating expenses. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.
	The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

RELATED_PARTY_TRANSACTIONS_AND

RELATED PARTY TRANSACTIONS AND COMMITMENTS	3 Months Ended
	Mar. 31, 2015
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE 4 – RELATED PARTY TRANSACTIONS AND COMMITMENTS
	(A)	Notes Payable	Interest Rate			Maturity Date	March 31, 2015		December 31, 2014
	-1	Note Payable - related party		10	%	Due on Demand		—		11,000
	Total						$	—	$	11,000
	(1) During the year ended December 31, 2013, a board of director advanced $15,000 to the Company. The advance bears interest at 10%, was unsecured and due on demand. The outstanding note balance at March 31, 2015 was fully paid.
	(B) Commitments
	During the year ended December 31, 2013, the Company entered into a royalty agreement having a term of 75 years, with a principal stockholder and a relative of the principal stockholder, whereas the Company is required to pay royalty fees based on a percentage of gross sales. As of March 31, 2015, the Company advanced a total of $83,930 to offset future royalties to be earned. Sales requiring royalties of $467 have occurred as of March 31, 2015.

EQUITY

EQUITY	3 Months Ended
	Mar. 31, 2015
Equity [Abstract]
Shareholders' Equity and Share-based Payments [Text Block]	NOTE 5 – EQUITY
	(A) Common Stock Issued for Cash
	Period Ended March 31, 2015
	The Company issued 2,507,000 shares of common stock for $1,253,500 ($0.50/share) and
	6,250 shares of common stock for $25,000 ($4.00/share).
	(B) Direct Offering Costs
	Period Ended March 31, 2015
	During the three months ended March 31, 2015, the Company issued 2,507,000 shares of common stock for $1,253,500 ($0.50/share) and issued 6,250 shares of common stock for $25,000 ($4.00/share) The Company paid direct offering costs of $95,500 (5% or 10% of gross proceeds). As a result of the offering, the Company also issued 189,000 fully vested, non-forfeitable warrants as a direct offering cost, which had no effect on the statement of stockholders’ equity and had a fair value of $87,355 (see Note 5(C) for additional details) based upon the following management assumptions:
	Exercise price		$	0.5
	Expected dividends			0%
	Expected volatility			157.54%
	Risk free interest rate			1.18% - 1.50%
	Expected life of warrants			5 years
	(C) Warrants issued for Services
	Period Ended March 31, 2015
	During the period ended March 31, 2015, the Company issued 631,000 fully vested, non-forfeitable warrants to employees and consultants for services having a fair value of $291,710 based upon the following management assumptions:
	Exercise price		$	0.5
	Expected dividends			0%
	Expected volatility			157.54%
	Risk free interest rate			1.46% - 1.76%
	Expected life of warrants			5 years
	(D) Warrants
	The following is a summary of the Company’s warrant activity:
									Weighted Average
									Remaining
						Weighted Average			Contractual Life
			Number of Warrants			Exercise Price			(in Years)
	Outstanding - December 31, 2014			1,926,900			0.5			4.6
	Granted			820,000			0.5			5
	Exercised			-			-			-
	Cancelled/Forfeited			-			-			-
	Outstanding - March 31, 2015			2,746,900			0.5			4.6
	Exercisable - March 31, 2015			2,746,900			0.5			4.6
	As of March 31, 2015:
										Weighted Average
	Exercise			Warrants			Warrants			Remaining
	Price			Outstanding			Exercisable			Contractual Life
	$	0.5			2,746,900			2,746,900			4.6 years
					2,746,900			2,746,900			4.6 years
	(E) Common Stock Issued for Services
	During the period ended March 31, 2015, the Company issued 100,000 shares of common stock to employees for services having a fair value of $50,000 ($0.50/share) based upon the most recent cash offering price.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
Subsequent Events [Text Block]	NOTE 6 – SUBSEQUENT EVENTS
	The Company has evaluated for subsequent events between the balance sheet date of March 31, 2015 and May 5, 2015, the date the financial statements were available to be issued, and concluded that events or transactions occurring during that period requiring recognition or disclosure have been made.
	Warrants
	As a result of 6,250 shares issued under our second private placement in March 2015, the Company also issued 417 fully vested non-forfeitable warrants as direct offering costs, and 3,125 fully vested non-forfeitable warrants associated with the number of shares. These warrants had no net effect on the statement of stockholders’ equity and had a fair value of $1,683 based upon the following management assumptions:
	Exercise price	$	0.5
	Expected dividends		0%
	Expected volatility		157.54%
	Risk free interest rate		1.51%
	Expected life of warrants		5 years
	Board of Directors
	On April 15, 2015, by unanimous approval of the Company’s Board of Directors, the following modifications were made to the Company’s By-Laws: 1) the date of the Company’s annual stockholder meeting date was changed from the second Wednesday of April to a date on or before October 31 of that fiscal year; 2) the notification period for a Board of Directors meeting was reduced from three to two business days; and 3) correction of certain typographical errors.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents
	For purposes of the statement of cash flows, the Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company had no cash equivalents at March 31, 2015 and December 31, 2014.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
	In preparing financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses in the statement of operations. Actual results could differ from those estimates.
Consolidation, Policy [Policy Text Block]	Principles of Consolidation
	The accompanying unaudited interim condensed consolidated financial statements include the accounts of Zero Gravity Solutions, Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Inventory, Policy [Policy Text Block]	Inventory
	Inventory is valued on a lower of first-in, first out (FIFO) cost or market basis. At March 31, 2015 raw materials on hand was $8,962 and finished product inventory was valued at $16,141.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment
	Property and equipment is stated at cost, less accumulated depreciation. Expenditures for maintenance and repairs are charged to expense as incurred.
	Depreciation is computed on a straight-line basis over estimated useful lives. Property and equipment is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. There were no impairment charges taken during the period ended March 31, 2015.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments and Derivative Financial Instruments
	The Company applies the accounting guidance under Financial Accounting Standards Board (“FASB”) ASC 820-10, “Fair Value Measurements”, as well as certain related FASB staff positions.  This guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact business and considers assumptions that marketplace participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of non-performance.
	The guidance also establishes a fair value hierarchy for measurements of fair value as follows:
	·	Level 1 – quoted market prices in active markets for identical assets or liabilities.
	·	Level 2 - inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	·	Level 3 – unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	The carrying amounts of the Company’s short-term financial instruments, accounts payable and accrued liabilities and notes payable – related party, approximate fair value due to the relatively short period to maturity for these instruments.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock based compensation
	We account for stock options in accordance with Accounting Standards Codification (“ASC”) 718: Compensation - Stock Compensation (“ASC 718”). ASC 718 requires generally that all equity awards be accounted for at their “fair value.” This fair value is measured on the grant date for stock-settled awards, and at subsequent exercise or settlement for cash-settled awards. Fair value is equal to the underlying value of the stock for “full-value” awards such as restricted stock and performance shares, and estimated using an option-pricing model with traditional inputs for “appreciation” awards such as stock options and stock appreciation rights.
	Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from our initial estimates: previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in general and administrative expense.
Earnings Per Share, Policy [Policy Text Block]	Basic (Loss) per Common Share
	Basic (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity.
	The Company had the following potential common stock equivalents at March 31, 2015 and December 31, 2014:
			31-Mar-15		December 31. 2014
	Stock Warrants (Exercise price - $.50/share) (see Note 5)			2,746,900		1,926,900
	Total common stock equivalents			2,746,900		1,926,900
Research and Development Expense, Policy [Policy Text Block]	Research and Development
	The Company expenses all research and development costs as incurred for which there is no alternative future use.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency Transactions
	The consolidated financial statements are presented in United States Dollars. The Company has a bank account in foreign currency. The balance of this bank account was translated from its local currency (British Pounds) into the reporting currency, U.S. dollars, using period end exchange rates. The resulting translation adjustments were recorded as a separate component of accumulated other comprehensive loss. Revenues and expenses were translated using weighted average exchange rate for the period.
	Transaction gains and losses resulting from foreign currency transactions were recorded as foreign exchange gains or losses in the consolidated statement of operations. The Company did not enter into any financial instruments to offset the impact of foreign currency fluctuations.
Income Tax, Policy [Policy Text Block]	Income Taxes
	The Company accounts for income taxes in accordance with accounting guidance now codified as FASB ASC Topic 740, “Income Taxes,” which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all deferred tax assets will not be realized.
	Accounting guidance now codified as FASB ASC Topic 740-20, “Income Taxes – Intraperiod Tax Allocation,” clarifies the accounting for uncertainties in income taxes recognized in accordance with FASB ASC Topic 740-20 by prescribing guidance for the recognition, de-recognition and measurement in financial statements of income tax positions taken in previously filed tax returns or tax positions expected to be taken in tax returns, including a decision whether to file or not to file in a particular jurisdiction. FASB ASC Topic 740-20 requires that any liability created for unrecognized tax benefits is disclosed. The application of FASB ASC Topic 740-20 may also affect the tax bases of assets and liabilities and therefore may change or create deferred tax liabilities or assets. The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense.
	At March 31, 2015 and December 31, 2014, the Company did not record any liabilities for uncertain tax positions.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Schedule of Weighted Average Number of Shares [Table Text Block]	The Company had the following potential common stock equivalents at March 31, 2015 and December 31, 2014:
		31-Mar-15		December 31. 2014
	Stock Warrants (Exercise price - $.50/share) (see Note 5)		2,746,900		1,926,900
	Total common stock equivalents		2,746,900		1,926,900

RELATED_PARTY_TRANSACTIONS_AND1

RELATED PARTY TRANSACTIONS AND COMMITMENTS (Tables)	3 Months Ended
	Mar. 31, 2015
Related Party Transactions [Abstract]
Schedule of Short-term Debt [Table Text Block]	(A)	Notes Payable	Interest Rate			Maturity Date	March 31, 2015		December 31, 2014
	-1	Note Payable - related party		10	%	Due on Demand		—		11,000
	Total						$	—	$	11,000
	(1) During the year ended December 31, 2013, a board of director advanced $15,000 to the Company. The advance bears interest at 10%, was unsecured and due on demand. The outstanding note balance at March 31, 2015 was fully paid.

EQUITY_Tables

EQUITY (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	The following is a summary of the Company’s warrant activity:
									Weighted Average
									Remaining
						Weighted Average			Contractual Life
			Number of Warrants			Exercise Price			(in Years)
	Outstanding - December 31, 2014			1,926,900			0.5			4.6
	Granted			820,000			0.5			5
	Exercised			-			-			-
	Cancelled/Forfeited			-			-			-
	Outstanding - March 31, 2015			2,746,900			0.5			4.6
	Exercisable - March 31, 2015			2,746,900			0.5			4.6
	As of March 31, 2015:
										Weighted Average
	Exercise			Warrants			Warrants			Remaining
	Price			Outstanding			Exercisable			Contractual Life
	$	0.5			2,746,900			2,746,900			4.6 years
					2,746,900			2,746,900			4.6 years
Warrants Issued For Services [Member]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Exercise price		$	0.5
	Expected dividends			0%
	Expected volatility			157.54%
	Risk free interest rate			1.46% - 1.76%
	Expected life of warrants			5 years
Direct Offering Cost [Member]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Exercise price		$	0.5
	Expected dividends			0%
	Expected volatility			157.54%
	Risk free interest rate			1.18% - 1.50%
	Expected life of warrants			5 years

SUBSEQUENT_EVENTS_Tables

SUBSEQUENT EVENTS (Tables) (Warrant [Member])	3 Months Ended
	Mar. 31, 2015
Warrant [Member]
Subsequent Event [Line Items]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Exercise price	$	0.5
	Expected dividends		0%
	Expected volatility		157.54%
	Risk free interest rate		1.51%
	Expected life of warrants		5 years

ORGANIZATION_HISTORY_AND_NATUR1

ORGANIZATION, HISTORY AND NATURE OF OPERATIONS (Details Textual)	3 Months Ended
	Mar. 31, 2015
Entity Incorporation, Date of Incorporation	19-Aug-83
Entity Incorporation, State Country Name	Delaware
Zero Gravity Solutions, Ltd. [Member]
Minority Interest Ownership Percentage By Parent	100.00%

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Stock Warrants (Exercise price - $.50/share) (see Note 6)	2,746,900	1,926,900
Total common stock equivalents	2,746,900	1,926,900

SUMMARY_OF_SIGNIFICANT_ACCOUNT4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Inventory, Raw Materials, Gross	$8,962
Inventory, Finished Goods, Gross	$16,141
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$0.50	$0.50

GOING_CONCERN_Details_Textual

GOING CONCERN (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Retained Earnings (Accumulated Deficit)	($5,587,185)		($4,485,661)
Net Cash Provided by (Used in) Operating Activities, Continuing Operations	($802,593)	($440,962)

RELATED_PARTY_TRANSACTIONS_AND2

RELATED PARTY TRANSACTIONS AND COMMITMENTS (Details) (USD $)	3 Months Ended
	Mar. 31, 2015		Dec. 31, 2014		Dec. 31, 2013
Short-term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage					10.00%
Notes Payable, Related Parties, Current	$0		$11,000		$15,000
Related Party, Note Payable One [Member]
Short-term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10.00%	[1]
Debt Instrument, Maturity Date, Description	Due on Demand	[1]
Notes Payable, Related Parties, Current	$0	[1]	$11,000	[1]
[1]	During the year ended December 31, 2013, a board of director advanced $15,000 to the Company. The advance bears interest at 10%, was unsecured and due on demand. The outstanding note balance at March 31, 2015 was fully paid.

RELATED_PARTY_TRANSACTIONS_AND3

RELATED PARTY TRANSACTIONS AND COMMITMENTS (Details Textual) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2013	Dec. 31, 2014
Short-term Debt [Line Items]
Royalty Term		75 years
Advance Royalties, Noncurrent	$83,930		$50,356
Royalty Revenue	467
Notes Payable, Related Parties, Current	$0	$15,000	$11,000
Debt Instrument, Interest Rate, Stated Percentage		10.00%

EQUITY_Details

EQUITY (Details) (Direct Offering Cost [Member], USD $)	3 Months Ended
	Mar. 31, 2015
Direct Offering Cost [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Exercise price	$0.50
Expected dividends	0.00%
Expected volatility	157.54%
Risk free interest rate, Minimum	1.18%
Risk free interest rate, Maximum	1.50%
Expected life of warrants	5 years

EQUITY_Details_1

EQUITY (Details 1) (Warrant [Member], Employees and Consultants [Member], USD $)	3 Months Ended
	Mar. 31, 2015
Warrant [Member] | Employees and Consultants [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Exercise price	$0.50
Expected dividends	0.00%
Expected volatility	157.54%
Risk free interest rate, Minimum	1.46%
Risk free interest rate, Maximum	1.76%
Expected life of warrants	5 years

EQUITY_Details_2

EQUITY (Details 2) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Exercise Price 0.50 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Warrants, Outstanding at Beginning Balance	2,746,900
Number of Warrants, Outstanding at Ending Period	2,746,900
Number of Warrants, Exercisable at Ending Period	2,746,900
Weighted Average Exercise Price, Outstanding at Beginning Balance	$0.50
Weighted Average Remaining Contractual Life, Outstanding at Ending Period (in years)	4 years 7 months 6 days
Weighted Average Remaining Contractual Life, Exercisable at Ending Period (in years)	4 years 7 months 6 days
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Warrants, Outstanding at Beginning Balance	1,926,900
Number of Warrants, Granted	820,000
Number of Warrants, Exercised	0
Number of Warrants, Cancelled/Forfeited	0
Number of Warrants, Outstanding at Ending Period	2,746,900	1,926,900
Number of Warrants, Exercisable at Ending Period	2,746,900
Weighted Average Exercise Price, Outstanding at Beginning Balance	$0.50
Weighted Average Exercise Price, Granted	$0.50
Weighted Average Exercise Price, Exercised	$0
Weighted Average Exercise Price, Cancelled/Forfeited	$0
Weighted Average Exercise Price, Outstanding at Ending Balance	$0.50	$0.50
Weighted Average Exercise Price, Exercisable at Ending Balance	$0.50
Weighted Average Remaining Contractual Life, Granted (in years)	5 years
Weighted Average Remaining Contractual Life, Outstanding at Ending Period (in years)	4 years 7 months 6 days	4 years 7 months 6 days
Weighted Average Remaining Contractual Life, Exercisable at Ending Period (in years)	4 years 7 months 6 days

EQUITY_Details_Textual

EQUITY (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Share Based Payment Award, Fair Value Assumption [Line Items]
Payments of Stock Issuance Costs	$95,500	$33,900
Common Stock [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Share Price	$4
Share Price1	$0.50
Stock Issued During Period Shares New Issues1	2,507,000
Stock Issued During Period Value New Issues1	1,253,500
Stock Issued During Period, Shares, New Issues	6,250
Stock Issued During Period, Value, New Issues	25,000
Common Stock [Member] | Issued one [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Share Price	$0.50
Stock Issued During Period, Shares, New Issues	2,507,000
Stock Issued During Period, Value, New Issues	1,253,500
Common Stock [Member] | Issued Two [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Share Price	$4
Stock Issued During Period, Shares, New Issues	6,250
Stock Issued During Period, Value, New Issues	25,000
Common Stock [Member] | Third Party [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Share Price	$0.50
Stock Issued During Period, Shares, Issued for Services	100,000
Stock Issued During Period, Value, Issued for Services	50,000
Warrant [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Payments of Stock Issuance Costs	95,500
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	189,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	87,355
Warrant [Member] | Employees and Consultants [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	631,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	$291,710

SUBSEQUENT_EVENTS_Details

SUBSEQUENT EVENTS (Details) (Warrant [Member], Subsequent Event [Member], USD $)	3 Months Ended
	Mar. 31, 2015
Warrant [Member] | Subsequent Event [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price	$0.50
Expected dividends	0.00%
Expected volatility	157.54%
Expected life of warrants	5 years
Risk free interest rate	1.51%

SUBSEQUENT_EVENTS_Details_Text

SUBSEQUENT EVENTS (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2015
Warrant [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	$87,355
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	189,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	$1,683
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	417
Subsequent Event [Member] | Private Placement [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues	6,250
Subsequent Event [Member] | Warrant [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	3,125